Found 8 matching trials
Study of TLR9 Agonist Vidutolimod (CMP-001) in Combination With Nivolumab vs. Nivolumab
PHASE2The main goal of this research study is to determine how nivolumab and nivo...
Location
UPMC Hillman Cancer Center
CMP-001 in Combination With Nivolumab Compared to Nivolumab Monotherapy in Subjects With Advanced Melanoma
PHASE2CMP-001-011 is a Phase 2/3 study of CMP-001 intratumoral (IT) and nivolumab...
Location
Mayo Clinic Arizona
Clinical Study of CMP-001 in Combination With Pembrolizumab or as a Monotherapy
PHASE1This study will be conducted in two parts: Part 1 will be conducted using a...
Location
Banner MD Anderson Cancer Center
CMP-001 in Combination With Nivolumab in Subjects With Advanced Melanoma
PHASE2CMP-001-010 is a Phase 2 study of CMP-001 intratumoral (IT) and nivolumab i...
A Trial To Find Out If Vidutolimod Together With Cemiplimab Is Safe And If It Works In Adult Participants With Advanced Cancer Or Metastatic Cancer
PHASE2The goal of this study is to learn if giving cemiplimab and vidutolimod tog...
Location
University of Alabama
Vidutolimod (CMP-001) in Combination With Nivolumab for the Treatment of Metastatic Castration Resistant Prostate Cancer
PHASE2This phase II trial tests whether vidutolimod with nivolumab works to destr...
Location
Emory University Hospital/Winship Cancer Institute
Compassionate Use of Vidutolimod
N/AProvide Compassionate Use of Vidutolimob...
Status
No Longer Available
Location
Multiple Locations
CMP-001 in Combination With Pembrolizumab in Subjects With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
PHASE2CMP-001-007 is a Phase 2 study of CMP-001 intratumoral (IT) and pembrolizum...
Location
University of Arkansas for Medical Sciences